Abstract: An embodiment engagement structure includes an engagement bracket including an upper end configured to be engaged with a side member of a vehicle and connected to a region in which the side member is to be engaged with a sub-frame, wherein the engagement bracket comprises an inclined portion inclined downward toward a rear side of the vehicle.

Abstract: A timing controller generates a second clock by using a first clock, generates a test pulse by using the second clock, and generates a plurality of test clocks by latching the test pulse. The timing controller determines whether the clock signal is normally generated, by using the number of a plurality of rising edges included in a cycle of the test pulse and the number of a plurality of falling edges included in the cycle of the test pulse. The plurality of rising edges are rising edges of the plurality of test clocks, and the plurality of falling edges are falling edges of the plurality of test clocks.

Abstract: A display driving device capable of performing overdriving compensation for image data using a comparison result between pixel data of a previous sub-pixel and pixel data of a current sub-pixel in units of horizontal lines includes overdriving controller configured to generate overdriving pixel data for a current sub-pixel based on a result of comparison between first pixel data for a previous sub-pixel and second pixel data for the current sub-pixel and a color arrangement pattern of the previous sub-pixel and the current sub-pixel in units of horizontal lines of image data, and a data driver configured to generate a source signal for the current sub-pixel based on one of the second pixel data and the overdriving pixel data to supply the source signal to the current sub-pixel.

Abstract: A display driving device capable of performing overdriving compensation for image data using a comparison result between pixel data of a previous sub-pixel and pixel data of a current sub-pixel in units of horizontal lines includes overdriving controller configured to generate overdriving pixel data for a current sub-pixel based on a result of comparison between first pixel data for a previous sub-pixel and second pixel data for the current sub-pixel and a color arrangement pattern of the previous sub-pixel and the current sub-pixel in units of horizontal lines of image data, and a data driver configured to generate a source signal for the current sub-pixel based on one of the second pixel data and the overdriving pixel data to supply the source signal to the current sub-pixel.

Abstract: Power consumption for display driving may be reduced by driving gate lines such that changes in pixel values are minimized

Abstract: The present invention discloses a low power driving system and timing controller for a display apparatus. The low power driving system may include: a timing controller configured to divide a display pattern into a static pattern and a dynamic pattern based on a difference between previous line data and current line data, and transmit a packet into which one of first option information corresponding to the static pattern and second option information corresponding to the dynamic pattern is applied; and a source driver configured to receive the packet, and perform a low power mode corresponding to the static pattern according to the first option information or perform adaptive charge sharing corresponding to the dynamic pattern according to the second option information.

Abstract: The present invention discloses a low power driving system and timing controller for a display apparatus. The low power driving system may include: a timing controller configured to divide a display pattern into a static pattern and a dynamic pattern based on a difference between previous line data and current line data, and transmit a packet into which one of first option information corresponding to the static pattern and second option information corresponding to the dynamic pattern is applied; and a source driver configured to receive the packet, and perform a low power mode corresponding to the static pattern according to the first option information or perform adaptive charge sharing corresponding to the dynamic pattern according to the second option information.

Abstract: Provided are urea derivatives of Formula I: with histone deacetylase (HDAC) inhibitory activity, optical isomers thereof, pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising the same. The provided urea derivatives of Formula I are selective histone deacetylase (HDAC) inhibitors and are effective for the treatment of histone deacetylase-mediated diseases such as malignant tumors, inflammatory diseases, rheumatoid arthritis, and neurodegeneration.

Abstract: The present invention relates to novel urea derivatives and, more particularly, to novel urea derivatives with histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, their use for the preparation of a medicaments comprising the same, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing novel urea derivatives. The novel urea derivatives as selective histone deacetylase (HDAC) inhibitors are effective for the treatment of histone deacetylase-mediated diseases such as malignant tumors, inflammatory diseases, rheumatoid arthritis, neurodegeneration, etc.

Abstract: The present invention relates to novel azaindole derivatives, and more particularly, to novel azaindole derivatives having histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof, the use thereof for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same, a method of treating disease using the pharmaceutical compositions, and methods for preparing the novel azaindole derivatives. The novel azaindole derivatives according to the present invention are selective histone deacetylase (HDAC) inhibitors, and may be used as agents for treating malignant tumor diseases, inflammatory diseases, rheumatoid arthritis, and neurodegenerative diseases.

Abstract: The present invention provides a novel indole derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compound according to the present invention can selectively inhibit histone deacetylase (HDAC), and thus can be used to effectively treat a disease associated with histone deacetylase (HDAC) activity.

Abstract: The present invention relates to novel azaindole derivatives, and more particularly, to novel azaindole derivatives having histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof, the use thereof for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same, a method of treating disease using the pharmaceutical compositions, and methods for preparing the novel azaindole derivatives. The novel azaindole derivatives according to the present invention are selective histone deacetylase (HDAC) inhibitors, and may be used as agents for treating malignant tumor diseases, inflammatory diseases, rheumatoid arthritis, and neurodegenerative diseases.

Abstract: The present invention relates to novel urea derivatives and, more particularly, to novel urea derivatives with histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, their use for the preparation of a medicaments comprising the same, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing novel urea derivatives. The novel urea derivatives as selective histone deacetylase (HDAC) inhibitors are effective for the treatment of histone deacetylase-mediated diseases such as malignant tumors, inflammatory diseases, rheumatoid arthritis, neurodegeneration, etc.

Abstract: Provided is a speaker module for a portable terminal which e includes a speaker housing having an opened front surface thus defining a resonance space, a radiation pattern disposed on a back surface of the speaker housing, and connection terminals which extend from the radiation pattern to be disposed in the resonance space, such that the radiation pattern is disposed on the speaker housing and the connection terminal for providing electric connection of the radiation pattern is disposed in an inner side of the speaker housing.

Abstract: The present invention relates to a novel hydroxamate derivatives, more specifically, to novel hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC), isomers thereof, pharmaceutically acceptable salts thereof, hydrates or solvates thereof, use for preparing pharmaceutical compositions, pharmaceutical compositions comprising the same, treatment method using said composition, and a preparing method of novel hydroxamate derivatives. The novel selective hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC) compositions can be used for treatment of inflammatory disease, rheumatoid arthritis, or degenerative disease.

Abstract: A structure for stacking Printed Board Assemblies (PBAs) in an electronic device is provided. The structure for stacking PBAs in an electronic device includes a clip mounted on a main Printed Circuit Board (PCB), a sub-PCB including a ground portion, a sub-PBA including the sub-PCB, and a clip header mounted on a lower part of the sub-PBA, wherein the clip header is inserted into the clip. Therefore, electronic components mounted on a main PCB can be shielded from outer electromagnetic waves while reducing material costs without using a shield can, and a sub-PBA can be stacked on the main PBA.

Abstract: Disclosed herein is a gas exhaust device of a retractor pretensioner for a vehicle, including a pinion connected to a belt weaving spool in a retractor body; a rack linearly transferred when engaged with the pinion; a rack transfer path formed between a pretensioner body and the retractor body, configured to guide the rack linearly toward the pinion; and a micro-gas generator (MGG) mounted on a side of a lower end of the pretensioner body to elevate the rack toward the pinion using gas generated by the MGG, wherein a gas moving aperture is formed to allow communication between an upper portion and a lower portion of the rack transfer path in a longitudinal direction in the rack, to elevate the rack using the gas generated from the MGG and simultaneously, move the rack toward the upper portion of the rack transfer path through the gas moving aperture.

Abstract: Disclosed herein is a gas exhaust device of a retractor pretensioner for a vehicle, including a pinion connected to a belt weaving spool in a retractor body; a rack linearly transferred when engaged with the pinion; a rack transfer path formed between a pretensioner body and the retractor body, configured to guide the rack linearly toward the pinion; and a micro-gas generator (MGG) mounted on a side of a lower end of the pretensioner body to elevate the rack toward the pinion using gas generated by the MGG, wherein a gas moving aperture is formed to allow communication between an upper portion and a lower portion of the rack transfer path in a longitudinal direction in the rack, to elevate the rack using the gas generated from the MGG and simultaneously, move the rack toward the upper portion of the rack transfer path through the gas moving aperture.

Abstract: Provided is a speaker module for a portable terminal which e includes a speaker housing having an opened front surface thus defining a resonance space, a radiation pattern disposed on a back surface of the speaker housing, and connection terminals which extend from the radiation pattern to be disposed in the resonance space, such that the radiation pattern is disposed on the speaker housing and the connection terminal for providing electric connection of the radiation pattern is disposed in an inner side of the speaker housing.

Abstract: The present invention relates to hydroxamate compounds of the following formula I, an isomer, pharmaceutically acceptable salt or hydrate thereof. The present invention also relates to a method for preparing the hydroxamate compounds, comprising allowing a compound of the following formula II to react with bromoaniline in the presence of an inorganic salt so as to prepare a compound of the following formula III.